Yishen Tongluo Prescription Treats Idiopathic Asthenospermia and Teratozoospermia in Patients with Syndrome of Kidney Deficiency and Collateral Obstruction by Alleviating Seminal Plasma Oxidative Stress
10.13422/j.cnki.syfjx.20250992
- VernacularTitle:益肾通络方治疗肾虚络阻型特发性弱畸精子症不育患者的临床疗效及对精浆氧化应激的影响
- Author:
Pengchao LI
1
;
Ruixuan HE
2
;
Zixue SUN
1
Author Information
1. Henan Province Hospital of Chinese Medicine/Second Affiliated Hospital of Henan University of Chinese Medicine，Zhengzhou 450002，China
2. The Second Clinical Medical School of Henan University of Chinese Medicine，Zhengzhou 450008，China
- Publication Type:Journal Article
- Keywords:
idiopathic asthenozoospermia and teratozoospermia;
Yishen Tongluo prescription;
syndrome of kidney deficiency and collateral obstruction;
efficacy evaluation
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2025;31(9):157-164
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the clinical effects of Yishen Tongluo Prescription in treating patients with idiopathic asthenozoospermia and teratozoospermia due to kidney deficiency and collateral obstruction， as well as the effects of this formula on biochemical indices and oxidative stress of seminal plasma. MethodsPatients who fulfilled the inclusion criteria were randomly allocated by the random number table method into an observation group （61 patients， including 2 dropped out and 59 completed） and a control group （61 patients， including 2 dropped out， 1 excluded， and 58 completed）. The observation group took Yishen Tongluo Prescription orally， 1 dose/day， and the control group took levocarnitine oral solution， 10 mL/time， 3 times/day. Both groups received a treatment course of 12 weeks and were followed up for 6 weeks. The percentage of progressive motile sperms （PR）， percentage of sperms with normal morphology， seminal plasma oxidative stress indicators ［malondialdehyde （MDA） and superoxide dismutase （SOD）］， seminal plasma biochemical indicators ［acid phosphatase （ACP）， zinc （Zn）， fructose （Fru）， and alpha-glucosidase （α-Glu）］， and traditional Chinese medicine （TCM） symptom scores were recorded for both groups before and after treatment. ResultsThe total response rate in the observation group was 76.3% （45/59）， which was higher than that （44.8%， 26/58） in the control group （χ2=12.120， P<0.05）. After treatment， both groups of patients showed increases in PR， percentage of sperms with normal morphology， and seminal plasma SOD level （P<0.05）， which were higher in the observation group than in the control group （P<0.05）. The MDA level and TCM symptom scores decreased in both groups after treatment （P<0.05）， and the decreases were more obvious in the observation group than in the control group （P<0.05）. After treatment， the seminal plasma levels of ACP， Zn， Fru， and α-Glu in the observation group （P<0.05） and that of α-Glu in the control group （P<0.05） rose. Moreover， the observation group had higher seminal plasma levels of ACP， Zn， Fru， and α-Glu than the control group （P<0.05）. Neither group showed obvious adverse reactions. ConclusionIn summaryYishen Tongluo prescription is able to improve the sperm vitality and reduce the sperm abnormality rate in infertile patients with idiopathic asthenozoospermia and teratozoospermia due to kidney deficiency and collateral obstruction. It may exert therapeutic effects by regulating the microenvironments of the epididymis， prostate， and seminal vesicles， thereby recovering the seminal plasma biochemical levels， enhancing the antioxidant capacity of seminal plasma， clearing excessive reactive oxygen species， and alleviating oxidative stress.
